| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | Taiwan | 3 | |
| #3 | Australia | 2 | |
| #4 | China | 2 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | Hong Kong | 1 | |
| #7 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hite Michael | 14 |
| #2 | Holmes Eric | 14 |
| #3 | Ostrander Gary K | 4 |
| #4 | Holmes Eric E | 1 |
| #5 | Ostrander Gary K Gk | 1 |
| #6 | Hite Michael M | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2014200052A1 | Formulations for enhanced bioavailability of orally administered polar agents | |
| CN104080450A | Formulations for enhanced bioavailability of zanamivir | |
| CN103536923A | Formulations for enhanced bioavailability of orally administered polar agents |